| Epigenomics | |
| Cover: | Epigenomics journal cover.jpg |
| Former Names: | --> |
| Abbreviation: | Epigenomics |
| Discipline: | Epigenomics |
| Language: | English |
| Editor: | James G. Herman, Jörg Tost |
| Publisher: | Future Medicine Ltd |
| History: | 2009–present |
| Frequency: | Monthly |
| Impact: | 4.778 |
| Impact-Year: | 2020 |
| Issn: | 1750-1911 |
| Eissn: | 1750-192X |
| Coden: | EPIGC7 |
| Oclc: | 746948365 |
| Website: | http://www.futuremedicine.com/loi/epi |
| Link5: | --> |
| Link5-Name: | --> |
Epigenomics is a peer-reviewed medical journal established in 2009 and published by Future Medicine. The editors-in-chief are James G. Herman (University of Pittsburgh Cancer Institute) and Jörg Tost . The journal covers all aspects of research on epigenomics and epigenetics and their implications for diagnosis, prognosis and therapeutics.
The journal is abstracted and indexed in EMBASE/Excerpta Medica, Index Medicus/MEDLINE/PubMed, Chemical Abstracts, BIOSIS Previews, Science Citation Index Expanded, and Scopus. According to the Journal Citation Reports, the journal has a 2017 impact factor of 4.979, ranking it 31st out of 166 journals in the category "Genetics & Heredity".[1]